CIK 0001818844
- Non-accelerated filer
- Smaller reporting company
Dogwood Therapeutics, Inc.
Sign in to watch- Ticker
- DWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 854314201
- Phone
- +1 866-620-8655
- Business address
- 44 MILTON AVENUE, ALPHARETTA, GA, 30009
- Former names
- Virios Therapeutics, Inc., Virios Therapeutics, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-05 | Duncan Gregory Scott CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (right to buy) | +330,000 | 330,000 | ||
| 2025-12-04 | Duncan Gregory Scott CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (right to buy) | +460,000 | 460,000 | ||
| 2025-06-27 | Duncan Gregory Scott CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2024-02-26 | Duncan Gregory Scott CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (right to buy) | +138,835 | 138,835 | ||
| 2023-08-17 | Duncan Gregory Scott CHIEF EXECUTIVE OFFICER | Purchase | +25,000 | $1.25 | $31K | 57,461 |
| 2022-12-12 | Duncan Gregory Scott CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (right to buy) | +410,000 | 410,000 | ||
| 2022-12-12 | Duncan Gregory Scott CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (right to buy) | +480,000 | 480,000 | ||
| 2022-06-23 | Duncan Gregory Scott CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2022-05-23 | Duncan Gregory Scott CHIEF EXECUTIVE OFFICER | Purchase | +7,500 | $4.52 | $34K | 32,461 |
| 2021-12-21 | Duncan Gregory Scott CHIEF EXECUTIVE OFFICER | Purchase | +5,000 | $5.52 | $28K | 24,961 |
| 2021-06-21 | Duncan Gregory Scott CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2021-04-06 | Duncan Gregory Scott Chief Executive Officer | Purchase | +382 | $6.36 | $2K | 19,961 |
| 2021-04-05 | Duncan Gregory Scott Chief Executive Officer | Purchase | +15,675 | $6.17 | $97K | 19,579 |
| 2021-04-05 | Duncan Gregory Scott Chief Executive Officer | Purchase | +15,675 | $6.17 | $97K | 19,579 |
| 2021-01-11 | Duncan Gregory Scott Chief Executive Officer | Grant or award · Stock Option (right to buy) | +21,796 | 435,921 | ||
| 2021-01-06 | Duncan Gregory Scott Chief Executive Officer | Exercise or conversion | +801 | $7.80 | $6K | 3,904 |
| 2021-01-06 | Duncan Gregory Scott Chief Executive Officer | Exercise or conversion · Warrant to Purchase Common Stock | −801 | 0 | ||
| 2020-12-21 | Duncan Gregory Scott Chief Executive Officer | Grant or award · Stock Option (right to buy) | +414,125 | 414,125 |
Page 1 of 1 · 18 trades